Industry Warns Of Cost-Shifting With Use Of Radiology Benefit Managers
This article was originally published in The Gray Sheet
Executive Summary
As policymakers consider the cost-saving prospects of requiring imaging scans to be pre-authorized by radiology benefit managers for Medicare coverage, industry is arguing that the policy may simply shift costs to providers.
You may also be interested in...
MedPAC Forwards More Ideas To Reduce Advanced Imaging Spending
The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.